Jul 24, 2026 07:26AM
Jul 22, 2026 07:31AM
Jul 22, 2026 07:30AM
Jul 2, 2026 07:31AM
Jul 2, 2026 07:30AM
Jul 1, 2026 07:30AM
Jul 1, 2026 07:30AM BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
Jul 1, 2026 07:30AM
Jun 28, 2026 04:00PM
Jun 28, 2026 04:00PM
Jun 22, 2026 09:05AM
May 27, 2026 07:30AM
May 27, 2026 07:30AM
May 12, 2026 07:30AM BridgeBio submits FDA application for rare disease drug encaleret
May 12, 2026 07:30AM
May 11, 2026 09:31AM
May 11, 2026 09:30AM
May 7, 2026 04:01PM
May 6, 2026 07:32AM
May 6, 2026 07:30AM
May 4, 2026 07:30AM BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
Mar 31, 2026 06:41AM
Mar 30, 2026 03:30PM
Mar 30, 2026 03:30PM
Mar 30, 2026 09:50AM
Mar 30, 2026 07:31AM
Mar 30, 2026 07:30AM
Mar 12, 2026 09:24AM Leerink Partners Reiterates Outperform Rating on BridgeBio Pharma (BBIO) after data presentation: "risk/reward skewed to the upside"
Mar 11, 2026 02:00PM
Mar 11, 2026 02:00PM
Feb 24, 2026 04:01PM
Feb 12, 2026 10:03AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 12, 2026 10:31AM BridgeBio reports $362.4 million in Attruby revenue for 2025
Jan 12, 2026 10:30AM
Dec 22, 2025 07:06AM
Dec 21, 2025 08:00PM
Nov 10, 2025 02:33AM
Nov 8, 2025 10:41AM
Oct 30, 2025 05:37AM
Oct 29, 2025 04:01PM BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates
Oct 29, 2025 07:00AM
Oct 29, 2025 07:00AM
Oct 27, 2025 10:22AM
Oct 27, 2025 07:00AM
Oct 27, 2025 07:00AM
Oct 24, 2025 08:29AM
Sep 28, 2025 11:15AM Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
Sep 6, 2025 02:30PM

326,426 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All